These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 23077312)

  • 1. Human anti-varicella-zoster virus (VZV) recombinant monoclonal antibody produced after Zostavax immunization recognizes the gH/gL complex and neutralizes VZV infection.
    Birlea M; Owens GP; Eshleman EM; Ritchie A; Traktinskiy I; Bos N; Seitz S; Azarkh Y; Mahalingam R; Gilden D; Cohrs RJ
    J Virol; 2013 Jan; 87(1):415-21. PubMed ID: 23077312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breadth and Functionality of Varicella-Zoster Virus Glycoprotein-Specific Antibodies Identified after Zostavax Vaccination in Humans.
    Sullivan NL; Reuter-Monslow MA; Sei J; Durr E; Davis CW; Chang C; McCausland M; Wieland A; Krah D; Rouphael N; Mehta AK; Mulligan MJ; Pulendran B; Ahmed R; Vora KA
    J Virol; 2018 Jul; 92(14):. PubMed ID: 29743372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutralizing anti-gH antibody of Varicella-zoster virus modulates distribution of gH and induces gene regulation, mimicking latency.
    Shiraki K; Daikoku T; Takemoto M; Yoshida Y; Suzuki K; Akahori Y; Okuno T; Kurosawa Y; Asano Y
    J Virol; 2011 Aug; 85(16):8172-80. PubMed ID: 21632752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of varicella-zoster virus-neutralizing antibodies in mice by co-infection with recombinant vaccinia viruses expressing the gH or gL gene.
    Nĕmecková S; Ludvíková V; Maresová L; Krystofová J; Hainz P; Kutinová L
    J Gen Virol; 1996 Feb; 77 ( Pt 2 )():211-5. PubMed ID: 8627224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A site of varicella-zoster virus vulnerability identified by structural studies of neutralizing antibodies bound to the glycoprotein complex gHgL.
    Xing Y; Oliver SL; Nguyen T; Ciferri C; Nandi A; Hickman J; Giovani C; Yang E; Palladino G; Grose C; Uematsu Y; Lilja AE; Arvin AM; Carfí A
    Proc Natl Acad Sci U S A; 2015 May; 112(19):6056-61. PubMed ID: 25918416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of neutralizing epitopes of varicella-zoster virus glycoprotein H.
    Akahori Y; Suzuki K; Daikoku T; Iwai M; Yoshida Y; Asano Y; Kurosawa Y; Shiraki K
    J Virol; 2009 Feb; 83(4):2020-4. PubMed ID: 19073736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune response to vaccinia virus recombinants expressing glycoproteins gE, gB, gH, and gL of Varicella-zoster virus.
    Kutinová L; Hainz P; Ludvíková V; Maresová L; Nĕmecková S
    Virology; 2001 Feb; 280(2):211-20. PubMed ID: 11162835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-glycoprotein H antibody impairs the pathogenicity of varicella-zoster virus in skin xenografts in the SCID mouse model.
    Vleck SE; Oliver SL; Reichelt M; Rajamani J; Zerboni L; Jones C; Zehnder J; Grose C; Arvin AM
    J Virol; 2010 Jan; 84(1):141-52. PubMed ID: 19828615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutralization epitope of the varicella-zoster virus gH:gL glycoprotein complex.
    Forghani B; Ni L; Grose C
    Virology; 1994 Mar; 199(2):458-62. PubMed ID: 7510086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation of therapeutic human monoclonal antibodies for varicella-zoster virus and the effect of light chains on the neutralizing activity.
    Suzuki K; Akahori Y; Asano Y; Kurosawa Y; Shiraki K
    J Med Virol; 2007 Jun; 79(6):852-62. PubMed ID: 17457901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Varicella-zoster virus gH:gL contains a structure reactive with the anti-human gamma chain of IgG near the glycosylation site.
    Yokoyama T; Ayabe S; Miyagi H; Sugano T; Otsu A; Sato H; Kageyama S; Fujii T; Shiraki K
    J Gen Virol; 2001 Feb; 82(Pt 2):331-334. PubMed ID: 11161270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Glycoprotein B Cytoplasmic Domain Lysine Cluster Is Critical for Varicella-Zoster Virus Cell-Cell Fusion Regulation and Infection.
    Yang E; Arvin AM; Oliver SL
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of neutralizing antibody against varicella-zoster virus (VZV) by VZV gp3 and cross-reactivity between VZV gp3 and herpes simplex viruses gB.
    Kitamura K; Namazue J; Campo-Vera H; Ogino T; Yamanishi K
    Virology; 1986 Feb; 149(1):74-82. PubMed ID: 2418583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell surface expression and fusion by the varicella-zoster virus gH:gL glycoprotein complex: analysis by laser scanning confocal microscopy.
    Duus KM; Hatfield C; Grose C
    Virology; 1995 Jul; 210(2):429-40. PubMed ID: 7618278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Varicella-zoster virus: molecular controls of cell fusion-dependent pathogenesis.
    Oliver SL; Zhou M; Arvin AM
    Biochem Soc Trans; 2020 Dec; 48(6):2415-2435. PubMed ID: 33259590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple regulatory effects of varicella-zoster virus (VZV) gL on trafficking patterns and fusogenic properties of VZV gH.
    Duus KM; Grose C
    J Virol; 1996 Dec; 70(12):8961-71. PubMed ID: 8971025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Varicella-zoster Virus gB and gE coexpression, but not gB or gE alone, leads to abundant fusion and syncytium formation equivalent to those from gH and gL coexpression.
    Maresova L; Pasieka TJ; Grose C
    J Virol; 2001 Oct; 75(19):9483-92. PubMed ID: 11533210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A functional YNKI motif in the short cytoplasmic tail of varicella-zoster virus glycoprotein gH mediates clathrin-dependent and antibody-independent endocytosis.
    Pasieka TJ; Maresova L; Grose C
    J Virol; 2003 Apr; 77(7):4191-204. PubMed ID: 12634377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutralizing human antibodies to varicella-zoster virus (VZV) derived from a VZV patient recombinant antibody library.
    Kausmally L; Waalen K; Løbersli I; Hvattum E; Berntsen G; Michaelsen TE; Brekke OH
    J Gen Virol; 2004 Dec; 85(Pt 12):3493-3500. PubMed ID: 15557222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A human monoclonal antibody against varicella-zoster virus glycoprotein III.
    Sugano T; Tomiyama T; Matsumoto Y; Sasaki S; Kimura T; Forghani B; Masuho Y
    J Gen Virol; 1991 Sep; 72 ( Pt 9)():2065-73. PubMed ID: 1654371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.